cGMP Pharmaceutical Stability Studies and ICH Storage

GMP pharmaceutical stability studies and ICH storage services supporting your drug product development, commercial stability studies, batch release and quality control testing
ICH pharmaceutical stability studies are an essential component of the development and lifecycle of pharmaceutical products, in particular, supporting the development process and IND / NDA submission activities. They allow evaluation of active pharmaceutical ingredient (API) stability or drug product stability under the influence of a variety of environmental factors such as temperature, humidity and light. Data from these studies enable recommended storage conditions, retest intervals and shelf lives to be established.
Selecting an experienced stability study service partner who offers efficient study management, flexible storage conditions and testing capabilities which satisfy all regulatory criteria for your real-time, accelerated or forced-degradation study requirements is key to success. Stability testing can present significant analytical hurdles and specialised knowledge is required to develop and validate stability indicating methods and perform analysis of leachable substances which migrate from pharmaceutical packaging into the product.
With a network of ICH stability storage facilities in the UK, US and Australia, we offer an extensive capacity and a range of conditions including climatic walk-in chambers, cabinets and refrigerated as well as freezer storage which are fully controlled and monitored with back up chambers at each site. All sites have 24-hour alarm systems with dedicated on call teams to react to the excursions from storage conditions. Our stability teams provide professionally managed Good Manufacturing Practice (cGMP) stability programs for even the most complex of dosage forms, APIs or product types including orally inhaled and nasal drug products (OINDP), biopharmaceuticals, consumer healthcare, medical devices or vaccines. We also offer a responsive and bespoke stability contingency and disaster recovery storage service to help you mitigate the risks associated with costly stability trials.
GMP Stability Services:
- cGMP registration stability programs
- Protocol design and program management
- Development and validation of stability indicating methods
- Stability testing for APIs, clinical trial materials, formulated products
- Tailored reporting (timepoint and final reports)
- Temperature cycling, freeze-thaw and shipping studies
- Stability contingency and disaster recovery storage
- Forced degradation testing
- Real-Time stability testing
- Accelerated stability testing
- Formulation stability testing
- Biologics stability studies
- Specialist expertise for OINDP stability programs
- Extractables / leachables
ICH Stability Conditions Available
We have an extensive range of ICH stability conditions available to our customers across the Intertek network:
- 21ºC / 45% RH
- 25ºC / 40% RH
- 25ºC / 60% RH
- 30ºC / 25% RH
- 30ºC / 35% RH
- 30ºC / 65% RH
- 30ºC / 75% RH
- 40ºC / 75% RH
- Cabinets 50 ºC, 57 ºC, 60 ºC
- Storage at 2-8ºC, -20ºC, -40ºC, -80ºC
- Photostability (ICH Options 1 & 2)
- Specialised conditions
- Freeze/thaw cycle tests
Stability Testing and Analysis
Our analytical laboratory network provides development and validation of stability-indicating methods utilizing a range of technologies to identify and quantify degradation products. Routine time point testing includes the usual tests such as assay and impurity analysis, dissolution, moisture, hardness, friability and disintegration. Intertek’s scientists have specialist expertise in OINDP testing for stability including particle or droplet size to provide data to drive understanding of the delivered formulation and delivery of the drug from the inhalation device. Our know-how in extractables and leachables studies means that we can ensure that the product container/packaging system demonstrates sufficient stability over the relevant lifecycle of your product.
Your Pharmaceutical Stability Program Partner
With over 20 years’ experience in conducting stability studies integrated with a comprehensive understanding of the latest developments in regional, country and ICH stability study guidelines, we offer a truly flexible stability outsourcing partnership. With integrated storage and testing capability, our expertise allows you to focus on your core business objectives. Bringing quality and safety to life, we offer Total Quality Assurance expertise to help you to meet and exceed quality, safety and regulatory standards for your pharmaceutical products.
Related Good Manufacturing Practice (cGMP):
Need help or have a question?
RESOURCES
WHITE PAPER DOWNLOADWHITE PAPER: Best Practice for Pharma Remote Audits
ARTICLE: Biomarker Development & Validation
WHITE PAPER: Strategic Partnerships with Contract Laboratory Organisations
WHITE PAPER: Mitigating Risks in Pharmaceutical Batch Release
WEBINAR: A Hi-Res Accurate Mass Spectrometry Validated Method for Nitrosamine Analysis
WEBINAR: Optimising Protein Impurity Analysis for AAV Capsids
REPORT:Peptide Therapeutics, Designing a Strategic QC Program
ARTICLE:Biophysical Characterisation of Biosimilars
WEBINAR: Glycosylation Site Specific Approaches for Antibody Therapies
WEBINAR: QC Strategy for Vaccine Development
eBOOK: Contingency Outsourcing Solutions
Access our comprehensive Digital Resource Library
Intertek Pharmaceutical Services
P.O. Box 470
291 Route 22 East
Salem Industrial Park
Whitehouse, NJ 08888
USA
Sample Size and Pricing Guide (PDF)
Download driving directions (PDF)
Download our Pharmaceutical Testing brochure (PDF)
Intertek Melbourn
GMP analytical and formulation services to the pharmaceutical, biotech and healthcare industries
Intertek Melbourn
Saxon Way, Melbourn
Herts, SG8 6DN
UK
Recent News:
Intertek expands facility as global demand increases for specialist OINDP development for biologics